Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Worst thing about Brian's resignation

Using a $2bn valuation for the patent portfolio, split 50/50 with TPL gives a price in the region of $2.50. Once expenses, taxes and other deductibles are offset it would drop to nearer $1.50. As the licensing fees would then be exhausted, what would lift the price to $5.00. Ascribing a p/e ratio greater than 1 would be redundant as all revenue has been factored.

Be well

Share
New Message
Please login to post a reply